drugset / Trial / NCT01267864

Valproate Versus Ketorolac Versus Metoclopramide

NCT01267864

Phase 4 Completed 330 enrolled Montefiore Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This randomized study is testing 3 different intravenous medications to see which one is best for acute migraine. The three medications are metoclopramide, valproate, and ketorolac.

Timeline

Start
2010-11
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified 30 mg Intravenous
Comparator Metoclopramide Small molecule 10 mg Intravenous
Comparator Valproate Small molecule 1 g Intravenous

Indications